QUANTIFICATION OF SUPERANTIGEN INDUCED IFN-GAMMA PRODUCTION BY COMPUTERIZED IMAGE-ANALYSIS - INHIBITION OF CYTOKINE PRODUCTION AND BLAST-TRANSFORMATION BY POOLED HUMAN-IGG
L. Bjork et al., QUANTIFICATION OF SUPERANTIGEN INDUCED IFN-GAMMA PRODUCTION BY COMPUTERIZED IMAGE-ANALYSIS - INHIBITION OF CYTOKINE PRODUCTION AND BLAST-TRANSFORMATION BY POOLED HUMAN-IGG, Journal of immunological methods, 175(2), 1994, pp. 201-213
A quantitative image analysis technique was developed to assess the cy
tokine content of immunocytochemically stained cytokine producing cell
s. Peripheral blood mononuclear cells were stimulated to induce cytoki
ne production with the superantigen streptococcal pyrogenic exotoxin-A
. We have developed a method based on indirect immunocytochemistry whi
ch identifies IFN-gamma producing cells by a characteristic morphology
generated by the accumulation of IFN-gamma in the Golgi organelle. An
image analysis technique permitted discrimination between these produ
cer cells and IFN-gamma binding target cells, which showed a different
appearance, with staining restricted to the cell surface membrane. A
semi-automated routine programme allowed the signal from a video camer
a to be processed by computerised image analysis methodology. This ena
bled us to measure the number of cytokine producing cells, the cytokin
e staining intensity in individual cells and the cell size expressed i
n actual cell area. The incidence of IFN-gamma producing cells determi
ned by image analysis measurement was compared to results obtained usi
ng manual microscopy. Cell size was assessed by the image analysis sys
tem as well as by now cytometry. Administration of pooled human IgG fo
r intravenous use (IVIg) to the superantigen stimulated cells signific
antly down-regulated IFN-gamma production, both in terms of the number
s of producer cells and in terms of cytokine stainingintensity in indi
vidual cells. In addition blast transformation of cells was substantia
lly reduced. These effects, mediated by IVIg, were also evident follow
ing delayed IVIg administration 24 h after the initial cell stimulatio
n.